获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Miraca Life Sciences

七月 2026

  • Home
  • Miraca Life Sciences

七月 2026的Miraca Life Sciences市场份额分析

成立年份2012
员工1001 - 5000
年营收--
miracalifesciences.com
Miraca Life Sciences
Miraca Life Sciences(包含公司地区分支机构)
  • miracalifesciences.com
    miracalifesciences.com
查看更多网站流量和参与度信息

Miraca Life Sciences热门域名的总访问量

了解Miraca Life Sciences市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

无数据可显示

无数据可显示

Miraca Life Sciences热门域名的平均访问时长

分析Miraca Life Sciences参与度指标。

过去 3 个月的平均访问时长

无数据可显示

无数据可显示

Miraca Life Sciences热门域名的平均页面浏览量

了解Miraca Life Sciences如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

无数据可显示

无数据可显示

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Miraca Life Sciences 采用的主要技术

这些是排名前 Miraca Life Sciences 的顶级域名所使用的网站技术(按行业分列)

视听媒体 (2)

移动设备 (2)

Apple Mobile Tags

Apple Mobile Tags

预订 (1)

Cvent

Cvent

转化和分析 (1)

Google Analytics

Google Analytics

更多技术

3

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Miraca Life Sciences 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Miraca Life Sciences acquired Plusdx on Nov 20th '25.Miraca Life Sciences ("MLS"), the leading provider of expert anatomic pathology services, today announced that it has acquired PLUS Diagnostics ("PLUS") from Water Street... * Johnson Controls Launches Enhanced Integrated Laboratory Services To Optimize R&D Facility Operations And Drive Scientific Productivity
新闻Water Street Healthcare Partners Llc sold assets to Miraca Life Sciences on May 1st '19.Miraca Life Sciences (“MLS”), the leading provider of expert anatomic pathology services, today announced that it has acquired PLUS Diagnostics (“PLUS”) from Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry.
新闻Biocept, Inc. partners with Miraca Life Sciences.Biocept, Inc. (NASDAQ: BIOC ), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has entered into a Promotion and Marketing Agreement with Miraca Life Sciences, Inc. (MLS) to market Biocept's Target Selector™ liquid biopsy tests and services to community-based oncologists and hematologists in specified sales territories in the United States.

查看 Miraca Life Sciences 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。